Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3448848 Title: FORME POLYMORPHE DE N-{6-(2-HYDROXYPROPAN-2-YL)-2-[2-(MÉTHYLSULFONYL)ÉTHYL]-2H-INDAZOL-5-YL}-6-(TRIFLUOROMÉTHYL)PYRIDINE-2-CARBOXAMIDE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
177185600
WO application number:
EP2017059767
Type:
European patent granted for BE
Status:
Open
Publication number:
3448848
WO publication number:
WO2017186703
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
25/04/2017
Grant date:
27/09/2023
EP publication date:
06/03/2019
WO publication date:
02/11/2017
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
27/09/2023
EP B1 publication date:
27/09/2023
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
25/04/2037

Applicant

Name:
Bayer Pharma Aktiengesellschaft
Legal Form:
From:
27/09/2023
Address:
Müllerstrasse 178, 13353 Berlin, Germany (DE)
To:

Agent

Name:
AWA Benelux SA
Legal Form:
From:
20/11/2023
Address:
Tour & Taxis - Royal Depot box: 216 Avenue du Port 86c, 1000, BRUXELLES, Belgium (BE)
To:

Inventor

1

Name:
THALER, Tobias
Legal Form:
Address:
50935 Köln, Germany (DE)

2

Name:
PLATZEK, Johannes
Legal Form:
Address:
12621 Berlin, Germany (DE)

3

Name:
GUIMOND, Nicolas
Legal Form:
Address:
42115 Wuppertal, Germany (DE)

Priority

Priority patent number:
16167652
Priority date:
29/04/2016
Priority country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
C07D 401/12; A61K 31/4439; A61P 35/00; A61P 37/00; A61P 9/00; A61P 27/00;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2023/18
Publication date:
09/10/2023
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202339
Publication date:
27/09/2023
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
30/04/2026
Annual fee number:
10
Annual fee amount:
185 Euro
Expected payer:
Last annual fee payment date:
26/03/2025
Last annual fee paid number:
9
Last annual fee paid amount:
165 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
20/11/2023 Outgoing Correspondence 1 PDF /4/2/2/3/5/0722353224/docs/177185600_0_outgoingcorrespondence_20231121_084543914.pdf
20/11/2023 Incoming Correspondence (Email) Cover letter 1 PDF /4/2/2/3/5/0722353224/docs/177185600_1_incomingcorrespondenceelectronic_20231121_084544225.pdf
20/11/2023 General Document Declaration of domicile 1 PDF /4/2/2/3/5/0722353224/docs/177185600_2_generaldocument_20231121_084544067.pdf